Finance

Lists
2348:HKG
Dawnrays Pharmaceutical (Holdings) Ltd
HK$0.99
+0.51%
(+0.0050) 1D
Sep 7, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2348...
Open
HK$0.99
High
HK$1.00
Low
HK$0.99
Mkt. cap
1.48B
Avg. vol.
0.00
Volume
52.00K
Dividend
6.36%
Quarterly dividend
HK$0.02
Ex-dividend date
May 27, 2026
P/E ratio
5.48
52-wk high
HK$1.26
52-wk low
HK$0.98
EPS
HK$0.18
Shares outstanding
1.51B
No. of employees
1K
Open
HK$0.99
High
HK$1.00
Low
HK$0.99
Mkt. cap
1.48B
Avg. vol.
0.00
Volume
52.00K
Dividend
6.36%
Quarterly dividend
HK$0.02
Ex-dividend date
May 27, 2026
P/E ratio
5.48
52-wk high
HK$1.26
52-wk low
HK$0.98
EPS
HK$0.18
Shares outstanding
1.51B
No. of employees
1K
About Dawnrays Pharmaceutical (Holdings) Ltd
CEO-
Employees1.07K
Founded1995
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
300.22M
300.22M
272.92M
272.92M
Cost of goods sold
166.39M
166.39M
146.33M
146.33M
Cost of revenue
166.39M
166.39M
146.33M
146.33M
Research and development expenses
13.33M
13.33M
17.51M
17.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
59.98M
59.98M
50.75M
50.75M
Operating expense
74.19M
74.19M
68.73M
68.73M
Total operating expenses
240.59M
240.59M
215.06M
215.06M
Operating income
59.63M
59.63M
57.86M
57.86M
Other non operating income
5.90M
5.90M
3.26M
3.26M
EBT including unusual items
59.65M
59.65M
79.08M
79.08M
EBT excluding unusual items
71.04M
71.04M
68.51M
68.51M
Income tax expense
4.95M
4.95M
17.41M
17.41M
Effective tax rate
8.30%
8.30%
22.01%
22.01%
Other operating expenses
886.50K
886.50K
466.00K
466.00K
Net income
54.70M
54.70M
61.67M
61.67M
Net profit margin
18.22%
18.22%
22.60%
22.60%
Earnings per share
-
-
-
-
Interest and investment income
6.85M
6.85M
6.91M
6.91M
Interest expense
-91.00K
-91.00K
-291.50K
-291.50K
Net interest expenses
6.76M
6.76M
6.62M
6.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
93.52M
93.52M
86.92M
86.92M
Gain or loss from assets sale
307.50K
307.50K
-
-
AI content may include mistakes. Learn more
Google apps